Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 166: 115363, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37660650

RESUMO

The purpose of this study was to examine the effects of nano-micelle curcumin (NMC)-induced redox imbalance on mitochondrial biogenesis and mitophagy. For this purpose, 24 mature male Wistar rats were divided into control and NMC-received groups (7.5, 15, and 30 mg/kg) groups. After 48 days, the Nrf1, Nrf2, and SOD (Cu/Zn) expression levels, as well as GSH/GSSG, NADP+ /NADPH relative balances (elements involved in redox homeostasis) were analyzed. Moreover, to explore the effect of NMC on mitochondrial biogenesis, the expression levels of Mfn1, Mfn2, OPA1, Fis1, and Drp1 were investigated. Finally, the expression levels of Parkin/PARK and PINK (genes involved in mitochondrial quality control), as well as LC3-I/II (mitophagy marker), were analyzed. Observations showed that NMC, dose-dependently, altered GSH/GSSG, NADP+ /NADPH relative balances, suppressed SOD expression and diminished its biochemical level, and repressed Nrf1 and Nrf2 expression levels. Moreover, it could change the Mfn1, Mfn2, OPA1, Fis1, and Drp1 expression pattern and stimulate the Parkin/PARK and PINK as well as LC3-I/II expression levels, dose-dependently. In conclusion, chronic and high-dose NMC is able to suppress the redox capacity by down-regulating the Nrf1 and Nrf2 expression. Finally, at high-dose levels, it is able to trigger mitophagy signaling in the testicles.


Assuntos
Curcumina , Biogênese de Organelas , Masculino , Ratos , Animais , Ratos Wistar , Curcumina/farmacologia , Dissulfeto de Glutationa , Mitofagia , NADP , Fator 2 Relacionado a NF-E2 , Testículo , Hidrolases , Micelas , Oxirredução , Superóxido Dismutase
2.
Pharm Biol ; 57(1): 799-806, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31760838

RESUMO

Context: Cinnamomum verum J. Presl. (Lauraceae) has a high number of polyphenols with insulin-like activity, increases glucose utilization in animal muscle, and might be beneficial for diabetic patients.Objective: This study evaluated the effectiveness of an ointment prepared from Cinnamomum verum hydroethanolic extract on wound healing in diabetic mice.Materials and methods: A total of 54 male BALB/c mice were divided into three groups: (1) diabetic non-treated group mice that were treated with soft yellow paraffin, (2 and 3) mice that were treated with 5 and 10% C. verum. Two circular full-thickness excisional wounds were created in each mouse, and the trial lasted for 16 d following induction of the wound. Further evaluation was made on the wound contraction ratio, histopathology parameters and mRNA levels of cyclin D1, insulin-like growth factor 1 (IGF-1), glucose transporter-1 (GLUT-1), total antioxidant capacity, and malondialdehyde of granulation tissue contents. HPLC apparatus was utilized to identify the compounds.Results: The HPLC data for cinnamon hydroethanolic extract identified cinnamaldehyde (11.26%) and 2-hydroxyl cinnamaldehyde (6.7%) as the major components. A significant increase was observed in wound contraction ratio, fibroblast proliferation, collagen deposition, re-epithelialization and keratin biosynthesis in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05). The expression level of cyclin D1, IGF1, GLUT 1 and antioxidant capacity increased in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05).Conclusions: Topical administration of C. verum accelerated wound healing and can possibly be employed in treating the wounds of diabetic patients.


Assuntos
Cinnamomum/química , Queratinas/efeitos dos fármacos , Extratos Vegetais/farmacologia , Reepitelização/efeitos dos fármacos , Cicatrização/efeitos dos fármacos , Administração Tópica , Animais , Antioxidantes/efeitos adversos , Diabetes Mellitus Experimental/induzido quimicamente , Fator de Crescimento Insulin-Like I/metabolismo , Queratinas/biossíntese , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Pomadas , Polifenóis , Pele/efeitos dos fármacos , Estreptozocina/farmacologia
3.
Kaohsiung J Med Sci ; 35(1): 24-32, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30844141

RESUMO

Several studies have reported the beneficial effects of Lawsonia inermis on wound healing, but the mechanism of action is still unknown. This study aimed to investigate the effectiveness of a new ointment formulation of hydroethanolic extract leaves of L. inermis on wound healing by gene expression of glucose transporter-1 (Glut-1) and insulin-like growth factor I (Igf-1) in Wistar rats. The animals were topically treated with different doses of L. inermis. An experimentally induced circular excisional wound model of 314 mm2 surface area was surgically created. The percentage of wound contraction and histopathological changes was assessed at different time points following wound induction. The expression of Glut-1 and Igf-1 was evaluated by reverse-transcription PCR. Topical administration of L. inermis, dose dependently, shortened inflammatory phase, accelerated cellular proliferation, and enhanced wound contraction ratio. It also improved revascularization, collagen deposition, and re-epithelialization rate and promoted intracytoplasmic carbohydrate storage (P < 0.05). Moreover, the mRNA levels of Igf-1 and Glut-1 were significantly higher in the L. inermis-treated groups than the control group (P < 0.05). Topical administration of L. inermis promoted the healing process by reducing tissue inflammation and increasing glucose uptake, which was mediated by up-regulating the expression of Igf-1 and Glut-1.


Assuntos
Etanol/química , Glucose/metabolismo , Inflamação/patologia , Lawsonia (Planta)/química , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Água/química , Cicatrização/efeitos dos fármacos , Administração Tópica , Fosfatase Alcalina/metabolismo , Antioxidantes/metabolismo , Carboidratos/análise , Epiderme/efeitos dos fármacos , Epiderme/metabolismo , Fibroblastos/efeitos dos fármacos , Fibroblastos/patologia , Flavonoides/análise , Transportador de Glucose Tipo 1/genética , Transportador de Glucose Tipo 1/metabolismo , Fator de Crescimento Insulin-Like I/genética , Fator de Crescimento Insulin-Like I/metabolismo , Queratinócitos/efeitos dos fármacos , Queratinócitos/metabolismo , Fenóis/análise , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reepitelização/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA